This protocol addresses patients with primary generalized dystonia or primary segmental dystonia — a setting in which an evidence-based first-line treatment approach is indicated.
Management in this population involves pharmacological therapy with oral medication and, where appropriate, botulinum toxin (BoNT) injections. The complete regimen — including specific agents, decision criteria, and sequencing — is available in the full protocol.
DOI: 10.1111/j.1468-1331.2010.03042.x